ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 797,63
0,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Strongbridge Biopharma PLC (SBBP)

  7. Strongbridge Biopharma PLC (SBBP) Actualités

SBBP

Strongbridge Biopharma (SBBP)

Strongbridge Biopharma PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SBBP
DateHeureSourceTitreSymboleSociété
11/02/202223h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SBBPStrongbridge Biopharma PLC
05/01/202218h51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SBBPStrongbridge Biopharma PLC
05/01/202218h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBBPStrongbridge Biopharma PLC
07/10/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202122h35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202122h28Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBBPStrongbridge Biopharma PLC
05/10/202122h01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
23/09/202122h01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
13/09/202113h14Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SBBPStrongbridge Biopharma PLC
08/09/202122h01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
08/09/202115h00TipRanksUnderstanding Strongbridge’s Newly Added Risk FactorNASDAQ:SBBPStrongbridge Biopharma PLC
31/08/202113h30GlobeNewswire Inc.Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With XerisNASDAQ:SBBPStrongbridge Biopharma PLC
30/08/202123h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBBPStrongbridge Biopharma PLC
30/08/202113h30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With XerisNASDAQ:SBBPStrongbridge Biopharma PLC
05/08/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:SBBPStrongbridge Biopharma PLC
02/08/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy StatementNASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202123h00Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202114h15GlobeNewswire Inc.Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in IssueNASDAQ:SBBPStrongbridge Biopharma PLC
29/07/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021NASDAQ:SBBPStrongbridge Biopharma PLC
26/07/202122h01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Dates of Special Shareholder Meetings in Connection with the Proposed Acquisition by Xeris Pharmaceuticals, Inc.NASDAQ:SBBPStrongbridge Biopharma PLC
19/07/202122h01GlobeNewswire Inc.Axogen, Inc. Appoints John H. Johnson to Board of DirectorsNASDAQ:SBBPStrongbridge Biopharma PLC
13/07/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) fo...NASDAQ:SBBPStrongbridge Biopharma PLC
09/07/202123h07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SBBPStrongbridge Biopharma PLC
03/06/202122h01GlobeNewswire Inc.Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Sy...NASDAQ:SBBPStrongbridge Biopharma PLC
25/05/202115h42TipRanksStrongbridge Shares Jump 12% on Acquisition Deal with XerisNASDAQ:SBBPStrongbridge Biopharma PLC
24/05/202122h58PR Newswire (US)Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creati...NASDAQ:SBBPStrongbridge Biopharma PLC
13/05/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc Announces U.S. Food & Drug Administration (FDA) Filing Acceptance of New Drug Application (NDA) fo...NASDAQ:SBBPStrongbridge Biopharma PLC
12/05/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:SBBPStrongbridge Biopharma PLC
06/05/202113h30GlobeNewswire Inc.Strongbridge Biopharma plc to Host First Quarter 2021 Financial Results Conference Call on May 12, 2021NASDAQ:SBBPStrongbridge Biopharma PLC
14/04/202114h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SBBPStrongbridge Biopharma PLC
 Showing the most relevant articles for your search:NASDAQ:SBBP

Dernières Valeurs Consultées

COIN
XIVUST
INVERSE
LSE
SRIW
Ubsetf Sriw
LSE
TN51
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés